Long-term outcome after haploidentical stem cell transplantation in children.
about
Review on Haploidentical Hematopoietic Cell Transplantation in Patients with Hematologic MalignanciesRecent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescentsDonor Specific Anti-HLA Antibody and Risk of Graft Failure in Haploidentical Stem Cell TransplantationModern approaches to HLA-haploidentical blood or marrow transplantationSide population cells in highly enriched CD34-positive cells from peripheral blood progenitor cells identify an immature subtype of hematopoietic progenitor cells but do not predict time to engraftment in patients treated with high-dose therapy.Hematopoietic stem cell transplantation for leukemiaImproved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.Optimal stem cell source for allogeneic stem cell transplantation for hematological malignancies.Strategies to harness immunity against infectious pathogens after haploidentical stem cell transplantationInfectious complications in cord blood and T-cell depleted haploidentical stem cell transplantationImpact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT.Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation.Searching for alternative hematopoietic stem cell donors for pediatric patients.HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.Current status of haploidentical stem cell transplantation for leukemia.Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responsesInfusion-related febrile reaction after haploidentical stem cell transplantation in children is associated with higher rates of engraftment syndrome and acute graft-versus-host disease.Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia.Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.Correlation of rabbit antithymocyte globulin serum levels and clinical outcomes in children who received hematopoietic stem cell transplantation from an alternative donor.Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation.Haploidentical related-donor hematopoietic cell transplantation in children using megadoses of CliniMACs-selected CD34(+) cells and a fixed CD3(+) dose.Managing a dual role--experiences and coping strategies of parents donating haploidentical G-CSF mobilized peripheral blood stem cells to their children.Haploidentical stem cell transplantation for children with acute leukaemia.In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation.Generation and flow cytometric quality control of clinical-scale TCRαβ/CD19-depleted grafts.Optimization of individualized graft composition: CD3/CD19 depletion combined with CD34 selection for haploidentical transplantation.Haploidentical stem cell transplantation for children with high-risk leukemia.Refinement of treatment strategies in ex vivo T-cell-depleted haploidentical SCT for pediatric patients.Delayed immune recovery following sequential orthotopic liver transplantation and haploidentical stem cell transplantation in erythropoietic protoporphyria.T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipientsLow mortality of children undergoing hematopoietic stem cell transplantation from 7 to 8/10 human leukocyte antigen allele-matched unrelated donors with the use of antithymocyte globulinJoint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter StudyTransplantation for Childhood Acute Lymphoblastic Leukemia
P2860
Q26749120-4A89B89B-B880-4B8A-8F76-650BBA0C2C17Q26750995-C415C2CE-3B48-4D3B-AD5D-526CB19FF8AFQ26767440-3CC23E26-0BB9-477B-A786-34FD39F4701AQ26797506-B323C988-859C-4757-8206-C4456996E165Q33959785-B8326224-4D02-4E72-BFE5-287E65639498Q34034180-25D35C36-A670-42E0-839C-29E95EF5E64CQ35060682-2E707E8F-F8C6-478F-85B2-8D22EA11CF04Q35073502-29B974EB-CEAA-4C01-BC10-79FD363EC475Q35083562-C8763135-20B1-4439-819C-664BBEAB37C1Q35485612-50A657FB-E31C-429A-BE34-F18E6AF6D49BQ35824950-D3332298-686D-4E09-86F8-ECD3B4F7AA16Q36687119-53378B41-2BE2-4418-BB64-24BD1E80230CQ36795165-D1576985-6F86-4552-8BB8-2340DEB46FDDQ37033846-BE306B98-F715-46D3-9C15-BFB430171BDBQ37078261-6D49D73D-5FCB-42B6-A85A-BB1A0C18DAB1Q37088557-85E79C7D-C9CE-4B0F-879A-6CC78DA4D38DQ37524719-B54DB947-60E9-4E8B-B949-A007B4F8EA33Q40140952-0E04836D-5542-47F1-A8B8-9C9744C54ADFQ40174651-6FE245DE-869E-4223-8C0D-A5718603F3BBQ40832630-0E0EF1D7-9F26-4B41-85B2-26ED1222D0EDQ40929855-9CD05DA1-5B63-456C-B4EF-53717184884AQ41953436-F7FD97E6-D941-4D76-BDB2-40FC503D3F70Q44362302-3EC57C24-3802-423B-A084-3825DCAC0B39Q47572077-B2FA946D-E175-4EB0-B3DD-8532D3A64416Q47602028-097502F0-C03F-49C4-A25E-92A56D44B774Q48680865-10972C4A-B200-4564-88E9-527E31F88E7FQ48941009-54752735-1ED2-48E0-994F-51922B4E9B6CQ50236616-C8275815-30D6-4F26-93C0-F2EC97AA8B4FQ53137621-8152DCCE-A0A4-40E3-8225-5FE445228EA4Q53255406-04383DD3-3624-413C-9D2F-8DA224FAC8F6Q53372558-FA618A9D-935A-43E8-A50A-7AAE72A61194Q58449860-AE38DAD0-B701-407C-A94C-50FC8171C615Q58618269-29A5BDE9-6A0E-4BAB-9801-12C73BAC5E69Q58781733-7CE28584-E795-41EE-8BE9-B126FEF0F679Q59094157-28D3A654-A50E-4193-BC97-2D5555123F44
P2860
Long-term outcome after haploidentical stem cell transplantation in children.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Long-term outcome after haploidentical stem cell transplantation in children.
@en
Long-term outcome after haploidentical stem cell transplantation in children.
@nl
type
label
Long-term outcome after haploidentical stem cell transplantation in children.
@en
Long-term outcome after haploidentical stem cell transplantation in children.
@nl
prefLabel
Long-term outcome after haploidentical stem cell transplantation in children.
@en
Long-term outcome after haploidentical stem cell transplantation in children.
@nl
P2093
P1476
Long-term outcome after haploidentical stem cell transplantation in children.
@en
P2093
David Martin
Dietrich Niethammer
Hans Scheel-Walter
Johann Greil
Michael Schumm
Monika Führer
Paul-Gerhard Schlegel
Peter Bader
Peter Lang
Rupert Handgretinger
P304
P356
10.1016/J.BCMD.2004.08.017
P577
2004-11-01T00:00:00Z